Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Sarepta Therapeutics (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's senior management will deliver a presentation on Monday, January 13, 2025, at 12:00 p.m. ET / 9:00 a.m. PT.
The presentation will be followed by a Q&A session starting at 12:20 p.m. ET / 9:20 a.m. PT. Investors and interested parties can access the live webcast through the Events & Presentations section of Sarepta's investor relations website. The presentation recording will remain available on the website for 90 days afterward. Attendees are advised to connect early to allow time for any necessary software downloads.
Sarepta Therapeutics (NASDAQ:SRPT), un leader nella medicina genetica di precisione per malattie rare, ha annunciato la sua partecipazione alla 43陋 Conferenza Sanitaria Annuale J.P. Morgan a San Francisco. La direzione senior dell'azienda presenter脿 un intervento luned矛 13 gennaio 2025, alle 12:00 ET / 9:00 PT.
La presentazione sar脿 seguita da una sessione di domande e risposte che inizier脿 alle 12:20 ET / 9:20 PT. Gli investitori e le parti interessate possono accedere al webcast live attraverso la sezione Eventi e Presentazioni del sito web per le relazioni con gli investitori di Sarepta. La registrazione della presentazione rimarr脿 disponibile sul sito per 90 giorni dopo. Si consiglia ai partecipanti di connettersi in anticipo per consentire tempo per eventuali download di software necessari.
Sarepta Therapeutics (NASDAQ:SRPT), un l铆der en medicina gen茅tica de precisi贸n para enfermedades raras, ha anunciado su participaci贸n en la 43陋 Conferencia Anual de Atenci贸n M茅dica de J.P. Morgan en San Francisco. La alta direcci贸n de la compa帽铆a realizar谩 una presentaci贸n el lunes 13 de enero de 2025, a las 12:00 p.m. ET / 9:00 a.m. PT.
La presentaci贸n ser谩 seguida de una sesi贸n de preguntas y respuestas que comenzar谩 a las 12:20 p.m. ET / 9:20 a.m. PT. Los inversores y partes interesadas pueden acceder a la transmisi贸n en vivo a trav茅s de la secci贸n de Eventos y Presentaciones en el sitio web de relaciones con inversores de Sarepta. La grabaci贸n de la presentaci贸n estar谩 disponible en el sitio durante 90 d铆as despu茅s. Se aconseja a los asistentes conectarse con anticipaci贸n para permitir tiempo para cualquier descarga de software necesaria.
靷爤頂勴儉 旃橂鞝� (NASDAQ:SRPT)電� 頋穩 歆堩櫂鞚� 鞙勴暅 鞝曤皜 鞙犾爠鞛� 鞚橅暀 攵勳暭鞚� 靹犽憪欤检瀽搿滌劀 靸岉攧霝�鞁滌姢旖旍棎靹� 鞐措Μ電� 鞝�43須� J.P. 氇贝 項姢旒�鞏� 旎嵓霟办姢鞐� 彀胳劃頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 瓿犾渼 瓴届榿歆勳潃 2025雲� 1鞗� 13鞚� 鞗旍殧鞚� 鞓ろ泟 12鞁�(ET) / 鞓れ爠 9鞁�(PT)鞐� 氚滍憸毳� 歆勴枆頃╇媹雼�.
氚滍憸 頉勳棎電� 鞓ろ泟 12鞁� 20攵�(ET) / 鞓れ爠 9鞁� 20攵�(PT)攵�韯� Q&A 靹胳厴鞚� 歆勴枆霅╇媹雼�. 韴瀽鞛� 氚� 鞚错暣甏�瓿勳瀽電� 靷爤頂勴儉鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼鞚� 鞚措菠韸� 氚� 氚滍憸 靹轨厴鞚� 韱淀暣 霛检澊敫� 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨姷雼堧嫟. 氚滍憸 雲鬼檾氤胳潃 攴� 頉� 90鞚� 霃欖晥 鞗轨偓鞚错姼鞐愳劀 鞝滉车霅╇媹雼�. 彀胳劃鞛愲摛鞚� 頃勳殧頃� 靻岉攧韸胳洦鞏� 雼れ毚搿滊摐 鞁滉皠鞚� 瓿犽牑頃橃棳 氙鸽Μ 鞝戩啀頃� 瓴冹潉 甓岇灔頃╇媹雼�.
Sarepta Therapeutics (NASDAQ:SRPT), un leader dans la m茅decine g茅n茅tique de pr茅cision pour les maladies rares, a annonc茅 sa participation 脿 la 43e Conf茅rence Annuelle sur les Soins de Sant茅 J.P. Morgan 脿 San Francisco. La direction senior de l'entreprise fera une pr茅sentation le lundi 13 janvier 2025, 脿 12h00 ET / 9h00 PT.
La pr茅sentation sera suivie d'une session de questions-r茅ponses qui commencera 脿 12h20 ET / 9h20 PT. Les investisseurs et les parties int茅ress茅es peuvent acc茅der 脿 la diffusion en direct via la section 脡v茅nements & Pr茅sentations du site web des relations investisseurs de Sarepta. L'enregistrement de la pr茅sentation restera disponible sur le site pendant 90 jours par la suite. Les participants sont conseill茅s de se connecter 脿 l'avance pour permettre le t茅l茅chargement de tout logiciel n茅cessaire.
Sarepta Therapeutics (NASDAQ:SRPT), ein f眉hrendes Unternehmen in der pr盲zisen Gentherapie f眉r seltene Krankheiten, hat seine Teilnahme an der 43. j盲hrlichen J.P. Morgan Healthcare-Konferenz in San Francisco bekannt gegeben. Die F眉hrungskr盲fte des Unternehmens werden am Montag, den 13. Januar 2025, um 12:00 Uhr ET / 9:00 Uhr PT eine Pr盲sentation halten.
Auf die Pr盲sentation folgt eine Q&A-Session, die um 12:20 Uhr ET / 9:20 Uhr PT beginnt. Investoren und Interessierte k枚nnen den Live-Stream 眉ber den Bereich Veranstaltungen & Pr盲sentationen auf der Investor-Relations-Website von Sarepta abrufen. Die Aufzeichnung der Pr盲sentation wird f眉r 90 Tage auf der Website verf眉gbar bleiben. Den Teilnehmern wird geraten, sich fr眉hzeitig zu verbinden, um ausreichend Zeit f眉r eventuelle Software-Downloads zu haben.
- None.
- None.
The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta鈥檚 website at and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit or follow us on , , and Facebook.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at . We encourage investors and potential investors to consult our website regularly for important information about us.
View source version on businesswire.com:
Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com
Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com
Source: Sarepta Therapeutics, Inc.
FAQ
When is Sarepta Therapeutics presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will SRPT's 2025 J.P. Morgan Healthcare Conference presentation be available online?
Where can investors watch Sarepta's J.P. Morgan Healthcare Conference presentation?
What time does the Q&A session start for SRPT's presentation at the J.P. Morgan Healthcare Conference?
